MALERIE MORIARTY: Open Payments
NPI 1689909731 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,409 in 13 payments from 9 companies in 2025. Trend: 2023 $29 · 2024 $635 · 2025 $1,409
Food & beverage: $1,409
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $453 |
| Medtronic, Inc. | 2 | $201 |
| ABIOMED | 1 | $149 |
| Neurocrine BioSciences, Inc. | 1 | $128 |
| Madrigal Pharmaceuticals | 1 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $124 |
| Alexion Pharmaceuticals, Inc. | 1 | $114 |
| COLOPLAST CORP | 1 | $99 |
| Boston Scientific Corporation | 1 | $15 |
Products named: INGREZZA, REZDIFFRA, OTEZLA, Kerendia, KRYSTEXXA, REPATHA, VENASEAL, Altis.
Industry payments across FL — which companies pay providers there.
